'Virologic response' presentation slideshows

Treatment of Hepatitis B

Treating hepatitis B and C (in South Africa ) Dr Mark Sonderup Division of Hepatology and Department of Medicine University of Cape Town & Groote Schuur Hospital . Treatment of Hepatitis B. Evolution of HBV Therapy. Peginterferon alfa-2a. Entecavir. Tenofovir. Lamivudine.

946 views • 72 slides

Individualni pristup u lije ? enju bolesnika s kroni ? nim C hepatitisom Smjernice Hrvatske konsenzus konferencije 2009

Individualni pristup u lije ? enju bolesnika s kroni ? nim C hepatitisom Smjernice Hrvatske konsenzus konferencije 2009. Prof.dr.sc. Adriana Vince Referentni Centar za dijagnostiku i lije ? enje virusnih hepatitisa RH Zagreb, 15.5.2009. Rezolucija o virusnom hepatitisu.

756 views • 53 slides

707 views • 46 slides

Choice of Endpoints for Salvage Studies

Choice of Endpoints for Salvage Studies. Choice of Endpoints. Clinical Endpoints AIDS-defining events Survival QOL Marker-based Endpoints for Efficacy HIV-1 RNA CD4. Choice of Endpoints (Cont.). Endpoints for Toxicity Time to treatment discontinuation

574 views • 40 slides

Pharmacology of Interferon

Pharmacology of Interferon. Interferon. Natural Interferons. Man Made Interferons (Recombinant). Interferon Basics. Interferons play an important role in the first line of defense against viral infections Interferons are part of the non-specific immune system

675 views • 30 slides

HIV and Latinos Living in U.S.A.

HIV and Latinos Living in U.S.A. Presenter: Thomas Donohoe. PT0147. What we know about Latinos and HIV/AIDS. Increase in number of new infections Increase in number of Latinos newly diagnosed with AIDS Late detection of HIV status and advanced disease Lack of access to healthcare

349 views • 22 slides

Clinical Significance of HIV-1 Drug Resistance

470 views • 22 slides

Mean Plasma Concentration (SD) at Steady State (ng/mL)

Virologic Determinants of 24-Week Efficacy of Atazanavir With or Without Ritonavir in Patients with Prior Failure on a Protease Inhibitor. C. Zala , A. Lazzarin, A. Casiro, B. Grinsztejn, L. Nieto, R. Salazar, E. Ledesma, T. Kelleher, R. McGovern, A. Rightmire, C. McLaren.

357 views • 21 slides

Management of Patients Co-infected with HCV and HIV: A Close Look at the Role for DAAs

Management of Patients Co-infected with HCV and HIV: A Close Look at the Role for DAAs. Susanna Naggie, MD Assistant Professor of Medicine Division of Infectious Diseases. Disclosures. Research: Vertex, Anandys, Synexis, Gilead, Merck, BMS

332 views • 19 slides

Systematic Review Research on Needle/Syringe Programs and Opiate Substitution Programs in Low and Middle Income Countrie

Systematic Review Research on Needle/Syringe Programs and Opiate Substitution Programs in Low and Middle Income Countries. Des Jarlais DC 1 , Feelemyer J. 1 , Arasteh K. 1 Hagan H. 2 1 The Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center

245 views • 18 slides

Sequential steps for managing and treating patients with chronic HCV infection, genotype 1 (4,6)

Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C January 15, 2009

264 views • 17 slides

Olga Znoyko Moscow State University of Dentistry and Medicine, Moscow

383 views • 17 slides

Joseph Park Advisor: Richard Gilroy, M.D. Kansas University Medical Center

325 views • 15 slides

VER X VE

VER X VE.

217 views • 15 slides

SILEN-C3 trial

256 views • 12 slides

NYU Medical Grand Rounds Clinical Vignette

NYU Medical Grand Rounds Clinical Vignette. Alexander Jow, PGY-3 February 21, 2012. U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS. Chief Complaint. U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.

213 views • 10 slides

Peginterferon alfa-2b + Ribavirin versus Interferon alfa-2b + Ribavirin

296 views • 7 slides

Emmet B. Keeffe, MD, MACP Professor of Medicine Chief of Hepatology

Treatment of Chronic Hepatitis B: Highlights From the 41st Annual Meeting of the European Association for the Study of the Liver. Emmet B. Keeffe, MD, MACP Professor of Medicine Chief of Hepatology Co-Director, Liver Transplant Program Stanford University Medical Center.

212 views • 7 slides

HCV genotypes distribution in the Krasnoyarsk region HIV-positive and HIV-negative populations

HCV genotypes distribution in the Krasnoyarsk region HIV-positive and HIV-negative populations. T. Chaychuk , N. Gankina, O. Rumyanceva Regional Center of AIDS Prevention, Krasnoyarsk, Russian Federation XVIII International AIDS Conference Vienna, July 18-23, 2010. Abstract WEPDB203.

179 views • 6 slides